Fraietta et al. expanded an individual clone of CAR T cells derived from a patient with chronic lymphocytic leukemia (CLL) and found a dominant population of the infused CD19-redirected CAR-T cells [43]. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.